TerraPower Isotopes (TPI) supports medical research and innovation by developing advanced radioisotope generators that enable efficient and automatic extraction of rare isotopes that have potentially life-saving qualities.

TerraPower’s assessment shows that select isotopic materials harvested from material that is stored by the U.S. Department of Energy (DOE) may be effectively used in Targeted Alpha Therapy for cancer patients. Researchers believe that these alpha emitting isotopes may help to destroy the targeted cancer cells with minimum damage to healthy cells.

TerraPower’s radiochemistry laboratory also supports other radioisotope development initiatives within the company as part of its nuclear innovation mission.